Aidigong Maternal & Child Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Aidigong Maternal & Child Health şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

-17.3%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-17.3%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	HK$0.0268
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Aidigong Maternal & Child Health Limited's (HKG:286) 44% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Nov 09

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Jun 06

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Mar 22

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Jul 06

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Jun 14

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Mar 27

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Dec 21

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Oct 13

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Sep 02

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Jun 29

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Aug 31

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Feb 21

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Jan 17

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Dec 12

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 286 şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 286 şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Aidigong Maternal & Child Health Piyasaya Karşı Temettü Getirisi

286 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (286)	0%
Pazarın Alt %25'i (HK)	3.3%
Pazarın En İyi %25'i (HK)	8.1%
Sektör Ortalaması (Healthcare)	4.1%
Analist tahmini (286) (3 yıla kadar)	n/a

Önemli Temettü: 286 şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 286 şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 286 Hong Kong piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 286 herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Aidigong Maternal & Child Health Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

New major risk - Shareholder dilution

Aidigong Maternal & Child Health Limited's (HKG:286) 44% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Now 33% undervalued

Now 26% undervalued

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

New minor risk - Share price stability

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Aidigong Maternal & Child Health Limited(SEHK:286) dropped from S&P Global BMI Index

First half 2024 earnings released: HK$0.33 loss per share (vs HK$0.22 loss in 1H 2023)

Aidigong Maternal & Child Health Limited to Report First Half, 2024 Results on Aug 30, 2024

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2024

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Aidigong Maternal & Child Health Limited has filed a Follow-on Equity Offering in the amount of HKD 62.09021 million.

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Insider selling

Chairman & CEO recently sold HK$8.4m worth of stock

New major risk - Share price stability

Chairman & CEO recently bought HK$1.4m worth of stock

New minor risk - Shareholder dilution

Chairman of the Board & CEO recently bought HK$247k worth of stock

Aidigong Maternal & Child Health Limited Announces Board and Committee Changes

Aidigong Maternal & Child Health Limited Announces Resignation of Guo Qifei Has as Non-Executive Director

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

First half 2023 earnings released: HK$0.005 loss per share (vs HK$0.014 loss in 1H 2022)

Aidigong Maternal & Child Health Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023

Aidigong Maternal & Child Health Limited to Report First Half, 2023 Results on Aug 31, 2023

Executive Director recently bought HK$6.3m worth of stock

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Full year 2022 earnings: EPS and revenues miss analyst expectations

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Now 22% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Director Appointments

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Aidigong Maternal & Child Health Limited announced that it expects to receive HKD 224.719102 million in funding from Zhuhai Deyou Bohui Enterprise Management Consulting (Limited Partnership)

Now 24% undervalued after recent price drop

Aidigong Maternal & Child Health Limited Announces Executive Changes

Price target decreased to HK$0.60

Less than half of directors are independent

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Now 25% undervalued

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.006 profit in 1H 2021)

Aidigong Maternal & Child Health Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Wong Kin Man as a Non-Executive Director

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Aidigong Maternal & Child Health Limited, Annual General Meeting, Jun 28, 2022

Aidigong Maternal & Child Health Limited Announces Resignation of Yang Zhibo as Non-Executive Director

Price target decreased to HK$0.65

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Chairman of the Board & CEO recently bought HK$1.2m worth of stock

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Independent Non Executive Director Yang Guang Mai has left the company

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

First half 2021 earnings released: EPS HK$0.006 (vs HK$0.007 in 1H 2020)

Aidigong Maternal & Child Health Limited has completed a Follow-on Equity Offering in the amount of HKD 117.8 million.

An unknown buyer entered into an agreement to acquire 49% stake Shenzhen Wanqi Marine Bio Tech Company Limited from Aidigong Maternal & Child Health Limited (SEHK:286) for HKD 25 million.

Full year 2020 earnings released: HK$0.10 loss per share (vs HK$0.004 profit in FY 2019)

Aidigong Maternal & Child Health Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

New 90-day high: HK$0.62

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

New 90-day low: HK$0.45

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

New 90-day low: HK$0.50

New 90-day low: HK$0.52

New 90-day low: HK$0.56

Aidigong Maternal & Child Health Limited to Report First Half, 2020 Results on Aug 28, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç